Discovery and Optimization of 1,3,4-Trisubstituted-pyrazolone Derivatives as Novel, Potent, and Nonsteroidal Farnesoid X Receptor (FXR) Selective Antagonists
Huang Huang(East China University of Science and Technology), Jian Li(Sir Run Run Shaw Hospital), Ruoqun Ma(East China University of Science and Technology), Xing Xu(Shanghai Jiao Tong University), Ying Yu(Wuhan University), Lili Chen(National Health Research Institutes), Yong Zhang(Hebei Medical University), Hui Jin(East China University of Science and Technology), Xu Shen(Chinese Academy of Sciences), Wenzhong Yan(East China University of Science and Technology), Zhenting Gao(East China University of Science and Technology), Hualiang Jiang(Chinese Academy of Sciences), Chenjing Li(Chinese Academy of Sciences), Jin Zhu(East China University of Science and Technology)
Cited by 63
Related Papers
Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells
|Nature|2015|925
Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin
|Development|2005|301